Literature DB >> 15364797

Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide.

Aun Yeong Chong1, Andrew D Blann, Jeetesh Patel, Bethan Freestone, Elizabeth Hughes, Gregory Y H Lip.   

Abstract

BACKGROUND: Congestive heart failure (CHF) is associated with endothelial perturbation (as defined by flow-mediated endothelial-dependent vasodilation [FMD, an index of endothelial dysfunction], circulating endothelial cells [CECs, an index of endothelial damage], or plasma indexes of endothelial damage/dysfunction [eg, von Willebrand factor (vWf) and soluble thrombomodulin (sTM)]) and raised plasma levels of brain natriuretic peptide (BNP, a peptide hormone associated with left ventricular systolic dysfunction and prognosis). However, the relations between these parameters are unclear. METHODS AND
RESULTS: To test the hypothesis that there is a relation between endothelial perturbation (defined by FMD, CECs, vWf, and sTM) and BNP in CHF, we studied these indexes in 30 patients with CHF who were compared with 20 age-matched control subjects. FMD, CECs, plasma vWf, and BNP levels (but not sTM) were all abnormal in patients with CHF. There were significant inverse correlations between FMD and vWf (P=0.001), CECs (P=0.002) and BNP (P=0.006) as well as a positive correlation between CECs and vWf (P=0.032). In multivariate analysis, BNP (P<0.001) and FMD (P<0.001) were both independently associated with CHF.
CONCLUSIONS: Ample evidence of endothelial cell damage/dysfunction in CHF cannot be fully explained by the variance in plasma BNP per se. Therefore, the routes by which these indexes influence the pathophysiology of CHF as well as predict adverse outcomes may be independent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364797     DOI: 10.1161/01.CIR.0000143073.60937.50

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  50 in total

1.  Temporal and venepuncture-related decline in circulating endothelial cell capture from mixed venous blood.

Authors:  Christopher J Boos; Deirdre A Lane; Delene Kang; Patrick K Y Goon; Andrew D Blann; Gregory Y H Lip
Journal:  J Thromb Thrombolysis       Date:  2006-10       Impact factor: 2.300

2.  The effect of preoperative aspirin administration on postoperative level of von Willebrand factor in off-pump coronary artery bypass surgery.

Authors:  Kaoru Matsuura; Mizuho Imamaki; Atsushi Ishida; Hitoshi Shimura; Masaru Miyazaki
Journal:  Heart Vessels       Date:  2009-05-24       Impact factor: 2.037

Review 3.  Antifibrotic therapies--emerging biomarkers as treatment end points.

Authors:  Jayant A Talwalkar
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-01       Impact factor: 46.802

4.  The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.

Authors:  Christine C Welles; Mary A Whooley; Beeya Na; Peter Ganz; Nelson B Schiller; Mintu P Turakhia
Journal:  Am Heart J       Date:  2011-08-09       Impact factor: 4.749

5.  NT-proBNP, race and endothelial function in the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sushan Yang; Shi Huang; Lori B Daniels; Joseph Yeboah; Joao A C Lima; Valentina Cannone; John C Burnett; Joshua A Beckman; J Jeffrey Carr; Thomas J Wang; Deepak K Gupta
Journal:  Heart       Date:  2019-05-31       Impact factor: 5.994

6.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

7.  Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage.

Authors:  G Liu; G-S Yin; J-y Tang; D-J Ma; J Ru; X-H Huang
Journal:  J Hum Hypertens       Date:  2014-02-20       Impact factor: 3.012

Review 8.  Safety and efficacy of new anticoagulants in patients with heart failure.

Authors:  Ron Pisters; Gregory Y H Lip
Journal:  Curr Heart Fail Rep       Date:  2013-03

9.  Endothelial progenitor cells: what use for the cardiologist?

Authors:  Aurangzeb Siddique; Eduard Shantsila; Gregory Yh Lip; Chetan Varma
Journal:  J Angiogenes Res       Date:  2010-02-22

Review 10.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.